JAZZ
Jazz Pharmaceuticals PLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$15.05B
P/E Ratio
1998.58
EPS
$0.12
Beta
0.27
52W High
$243.32
52W Low
$105.00
50-Day MA
$203.31
200-Day MA
$164.92
Dividend Yield
—
Profit Margin
0.66%
Forward P/E
13.09
PEG Ratio
1.00
About Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland.
Fundamentals
| Revenue (TTM) | $4.44B |
| Gross Profit (TTM) | $4.06B |
| EBITDA | $2.01B |
| Operating Margin | 23.50% |
| Return on Equity | 0.68% |
| Return on Assets | 6.92% |
| Revenue/Share (TTM) | $72.52 |
| Book Value | $70.30 |
| Price-to-Book | 3.32 |
| Price-to-Sales (TTM) | 3.39 |
| EV/Revenue | 3.962 |
| EV/EBITDA | 26.04 |
| Quarterly Earnings Growth (YoY) | 3.20% |
| Quarterly Revenue Growth (YoY) | 19.10% |
| Shares Outstanding | $62.74M |
| Float | $60.80M |
| % Insiders | 3.01% |
| % Institutions | 108.64% |
Historical Volatility
HV 10-Day
22.43%
HV 20-Day
32.97%
HV 30-Day
31.66%
HV 60-Day
29.16%
HV Rank
49.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($252.21 target)
6
Strong Buy9
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026